A randomized clinical trial of adjunctive ketamine anesthesia in electroconvulsive therapy for depression

被引:35
作者
Zhang, Minling [1 ]
Rosenheck, Robert [2 ]
Lin, Xiaoming [1 ]
Li, Qirong [1 ]
Zhou, Yanling [1 ]
Xiao, Yunshan [1 ]
Huang, Xiong [1 ]
Fan, Ni [1 ]
He, Hongbo [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Brain Hosp, Guangzhou Huiai Hosp, Guangzhou, Guangdong, Peoples R China
[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
基金
中国国家自然科学基金;
关键词
Ketamine; Anesthesia; Depression; ECT; TREATMENT-RESISTANT DEPRESSION; D-ASPARTATE ANTAGONIST; METHOHEXITAL ANESTHESIA; MAJOR DEPRESSION; PROPOFOL; SCHIZOPHRENIA; DISORDER; SCALE; MOOD; ECT;
D O I
10.1016/j.jad.2017.11.034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Electroconvulsive therapy (ECT) is a rapid acting and effective treatment for both major depressive disorder (MDD) and bipolar disorder (BP). Both propofol and ketamine are commonly used anesthetic agents but recent clinical studies suggest that ketamine has rapid-acting antidepressant properties, itself, at sub-anesthetic doses. Methods: A total of 77 inpatients (41 MDD and 36 BP) were randomly assigned to receive ECT with propofol (1 mg/kg) anesthesia or with ketamine (0.5 mg/kg) plus propofol (0.5 mg/kg). Depressive symptoms were assessed with the 24-item Hamilton Depression Rating Scale (HAMD-24) and Montgomery-Asberg Rating Scale (MADRS), before and after 1, 2, 4, and 6 ECT treatments, and 1-4 weeks following the last treatment. The MATRICS Consensus Cognitive Battery (MCCB) was evaluated at baseline, after the sixth ECT, and 1-4 weeks following the final ECT. Adverse effects were assessed at baseline and 4 weeks after the last treatment. Results: There were no significant differences in depressive symptoms, MCCB performance, or adverse effects between the treatment groups at any time. The electrical dose required to generate seizures in the ketamine plus propofol group was lower than that of the propofol only group at every time point. The seizure energy index and seizure duration in the ketamine plus propofol group was higher and longer than those in the propofol only group. Limitations: The diagnoses of MDD and BP were unevenly distributed across treatment groups. Conclusions: Ketamine plus propofol anesthesia in the ECT treatment of MDD and BP was not superior on any measure to propofol alone.
引用
收藏
页码:372 / 378
页数:7
相关论文
共 50 条
  • [41] Post-Electroconvulsive Therapy Recovery and Reorientation Time With Methohexital and Ketamine A Randomized, Longitudinal, Crossover Design Trial
    Yen, Tony
    Khafaja, Mohamad
    Lam, Nicholas
    Crumbacher, James
    Schrader, Ronald
    Rask, John
    Billstrand, Mary
    Rothfork, Jacob
    Abbott, Christopher C.
    JOURNAL OF ECT, 2015, 31 (01) : 20 - 25
  • [42] Significant treatment effect of add-on ketamine anesthesia in electroconvulsive therapy in depressive patients: A meta-analysis
    Li, Dian-Jeng
    Wang, Fu -Chiang
    Chu, Che-Sheng
    Chen, Tien-Yu
    Tang, Chia-Hung
    Yang, Wei-Cheng
    Chow, Philip Chik-keung
    Wu, Ching-Kuan
    Tseng, Ping-Tao
    Lin, Pao-Yen
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 (01) : 29 - 41
  • [43] Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression A Randomized Clinical Trial
    Quiroz, Jorge A.
    Tamburri, Paul
    Deptula, Dennis
    Banken, Ludger
    Beyer, Ulrich
    Rabbia, Michael
    Parkar, Nikhat
    Fontoura, Paulo
    Santarelli, Luca
    JAMA PSYCHIATRY, 2016, 73 (07) : 675 - 684
  • [44] Important Insights for the Use of Ketamine From Randomized Controlled Trials That Compared Ketamine With Electroconvulsive Therapy in Servere Depression
    Andrade, Chittaranjan
    JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (02)
  • [45] Ketamine and Electroconvulsive Therapy for Treatment-Refractory Depression
    Huang, Xing-Bing
    Zheng, Wei
    ALPHA PSYCHIATRY, 2023, 24 (06): : 244 - 246
  • [46] Magnetic Seizure Therapy Compared to Electroconvulsive Therapy for Schizophrenia: A Randomized Controlled Trial
    Jiang, Jiangling
    Li, Jin
    Xu, Yuanhong
    Zhang, Bin
    Sheng, Jianhua
    Liu, Dengtang
    Wang, Wenzheng
    Yang, Fuzhong
    Guo, Xiaoyun
    Li, Qingwei
    Zhang, Tianhong
    Tang, Yingying
    Jia, Yuping
    Daskalakis, Zafiris J.
    Wang, Jijun
    Li, Chunbo
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [47] Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial
    Kargar, M.
    Yoosefi, A.
    Akhondzadeh, S.
    Artonian, V.
    Ashouri, A.
    Ghaeli, P.
    PHARMACOPSYCHIATRY, 2015, 48 (07) : 268 - 273
  • [48] Adjunctive Simvastatin for Treatment-Resistant Depression: A Randomized Clinical Trial
    Husain, Muhammad Ishrat
    Chaudhry, Imran
    Khoso, Ameer Bukhsh
    Kiran, Tayyeba
    Khan, Nawaz
    Ahmad, Farooq
    Hodsoll, John
    Husain, Muhammad Omair
    Naqvi, Haider Ali
    Nizami, Asad Tamizuddin
    Chaudhry, Nasim
    Khan, Hazrat Ali
    Minhas, Fareed
    Meyer, Jeffrey H.
    Ansar, Moin
    Mulsant, Benoit H.
    Husain, Nusrat
    Young, Allan H.
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S104 - S104
  • [49] Study protocol for a parallel-group, double-blinded, randomized, controlled, noninferiority trial: the effect and safety of hybrid electroconvulsive therapy (Hybrid-ECT) compared with routine electroconvulsive therapy in patients with depression
    Rong, Han
    Xu, Shu-xian
    Zeng, Jing
    Yang, Ying-jia
    Zhao, Jie
    Lai, Wen-tao
    Chen, Li-chang
    Deng, Wen-feng
    Zhang, Xiangyang
    Zhang, Ying-li
    Li, Min-zhi
    Xiao, Li
    Xie, Xin-hui
    BMC PSYCHIATRY, 2019, 19 (01)
  • [50] Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
    Zarate, Carlos A., Jr.
    Brutsche, Nancy E.
    Ibrahim, Lobna
    Franco-Chaves, Jose
    Diazgranados, Nancy
    Cravchik, Anibal
    Selter, Jessica
    Marquardt, Craig A.
    Liberty, Victoria
    Luckenbaugh, David A.
    BIOLOGICAL PSYCHIATRY, 2012, 71 (11) : 939 - 946